3awm: Difference between revisions
No edit summary |
No edit summary |
||
| Line 1: | Line 1: | ||
==Cytochrome P450SP alpha (CYP152B1) wild-type with palmitic acid== | |||
<StructureSection load='3awm' size='340' side='right' caption='[[3awm]], [[Resolution|resolution]] 1.65Å' scene=''> | |||
== Structural highlights == | |||
<table><tr><td colspan='2'>[[3awm]] is a 1 chain structure with sequence from [http://en.wikipedia.org/wiki/Sphingomonas_paucimobilis Sphingomonas paucimobilis]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=3AWM OCA]. For a <b>guided tour on the structure components</b> use [http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=3AWM FirstGlance]. <br> | |||
</td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat"><scene name='pdbligand=HEM:PROTOPORPHYRIN+IX+CONTAINING+FE'>HEM</scene>, <scene name='pdbligand=MRD:(4R)-2-METHYLPENTANE-2,4-DIOL'>MRD</scene>, <scene name='pdbligand=PLM:PALMITIC+ACID'>PLM</scene></td></tr> | |||
<tr id='related'><td class="sblockLbl"><b>[[Related_structure|Related:]]</b></td><td class="sblockDat">[[3awp|3awp]], [[3awq|3awq]]</td></tr> | |||
<tr id='activity'><td class="sblockLbl"><b>Activity:</b></td><td class="sblockDat"><span class='plainlinks'>[http://en.wikipedia.org/wiki/Fatty-acid_peroxygenase Fatty-acid peroxygenase], with EC number [http://www.brenda-enzymes.info/php/result_flat.php4?ecno=1.11.2.4 1.11.2.4] </span></td></tr> | |||
<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=3awm FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=3awm OCA], [http://www.rcsb.org/pdb/explore.do?structureId=3awm RCSB], [http://www.ebi.ac.uk/pdbsum/3awm PDBsum]</span></td></tr> | |||
</table> | |||
<div style="background-color:#fffaf0;"> | |||
== Publication Abstract from PubMed == | |||
Cytochrome P450(SPalpha) (CYP152B1) isolated from Sphingomonas paucimobilis is the first P450 to be classified as a H(2)O(2)-dependent P450. P450(SPalpha) hydroxylates fatty acids with high alpha-regioselectivity. Herein we report the crystal structure of P450(SPalpha) with palmitic acid as a substrate at a resolution of 1.65 A. The structure revealed that the C(alpha) of the bound palmitic acid in one of the alternative conformations is 4.5 A from the heme iron. This conformation explains the highly selective alpha-hydroxylation of fatty acid observed in P450(SPalpha). Mutations at the active site and the F-G loop of P450(SPalpha) did not impair its regioselectivity. The crystal structures of mutants (L78F and F288G) revealed that the location of the bound palmitic acid was essentially the same as that in the WT, although amino acids at the active site were replaced with the corresponding amino acids of cytochrome P450(BSbeta) (CYP152A1), which shows beta-regioselectivity. This implies that the high regioselectivity of P450(SPalpha) is caused by the orientation of the hydrophobic channel, which is more perpendicular to the heme plane than that of P450(BSbeta). | |||
Crystal structure of H2O2-dependent cytochrome P450SPalpha with its bound fatty acid substrate: insight into the regioselective hydroxylation of fatty acids at the alpha position.,Fujishiro T, Shoji O, Nagano S, Sugimoto H, Shiro Y, Watanabe Y J Biol Chem. 2011 Aug 26;286(34):29941-50. Epub 2011 Jun 30. PMID:21719702<ref>PMID:21719702</ref> | |||
== | From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.<br> | ||
</div> | |||
==See Also== | |||
*[[Cytochrome P450|Cytochrome P450]] | |||
== References == | |||
<references/> | |||
__TOC__ | |||
</StructureSection> | |||
[[Category: Fatty-acid peroxygenase]] | [[Category: Fatty-acid peroxygenase]] | ||
[[Category: Sphingomonas paucimobilis]] | [[Category: Sphingomonas paucimobilis]] | ||
[[Category: Fujishiro, T | [[Category: Fujishiro, T]] | ||
[[Category: Nagano, S | [[Category: Nagano, S]] | ||
[[Category: Shiro, Y | [[Category: Shiro, Y]] | ||
[[Category: Shoji, O | [[Category: Shoji, O]] | ||
[[Category: Sugimoto, H | [[Category: Sugimoto, H]] | ||
[[Category: Watanabe, Y | [[Category: Watanabe, Y]] | ||
[[Category: Cytochrome p450]] | [[Category: Cytochrome p450]] | ||
[[Category: Oxidoreductase]] | [[Category: Oxidoreductase]] | ||
[[Category: Peroxygenase]] | [[Category: Peroxygenase]] | ||
Revision as of 17:17, 18 December 2014
Cytochrome P450SP alpha (CYP152B1) wild-type with palmitic acidCytochrome P450SP alpha (CYP152B1) wild-type with palmitic acid
Structural highlights
Publication Abstract from PubMedCytochrome P450(SPalpha) (CYP152B1) isolated from Sphingomonas paucimobilis is the first P450 to be classified as a H(2)O(2)-dependent P450. P450(SPalpha) hydroxylates fatty acids with high alpha-regioselectivity. Herein we report the crystal structure of P450(SPalpha) with palmitic acid as a substrate at a resolution of 1.65 A. The structure revealed that the C(alpha) of the bound palmitic acid in one of the alternative conformations is 4.5 A from the heme iron. This conformation explains the highly selective alpha-hydroxylation of fatty acid observed in P450(SPalpha). Mutations at the active site and the F-G loop of P450(SPalpha) did not impair its regioselectivity. The crystal structures of mutants (L78F and F288G) revealed that the location of the bound palmitic acid was essentially the same as that in the WT, although amino acids at the active site were replaced with the corresponding amino acids of cytochrome P450(BSbeta) (CYP152A1), which shows beta-regioselectivity. This implies that the high regioselectivity of P450(SPalpha) is caused by the orientation of the hydrophobic channel, which is more perpendicular to the heme plane than that of P450(BSbeta). Crystal structure of H2O2-dependent cytochrome P450SPalpha with its bound fatty acid substrate: insight into the regioselective hydroxylation of fatty acids at the alpha position.,Fujishiro T, Shoji O, Nagano S, Sugimoto H, Shiro Y, Watanabe Y J Biol Chem. 2011 Aug 26;286(34):29941-50. Epub 2011 Jun 30. PMID:21719702[1] From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine. See AlsoReferences
|
| ||||||||||||||||||||